Simeprevir (Olysio®)
NICE TA 331. NHSE clinical commissioning policy statement: Treatment of chronic hepatitis C in patients with cirrhosis
- Traffic LightRed
- BNF5.3.3.2
- Licensed IndicatorsIn combination with peginterferon alfa and ribavirin for treating genotypes 1 and 4 chronic hepatitis C
- ReferenceAPC July 14 , May 15, Sep 15
- Criteria
- ProvisionalNo
Do you want to add this to your CPD record?
Did you find this page helpful?